June 5, 2018, Vol 319, No. 21, Pages 2149-2244
Value-Based Pricing and Patient Access for Specialty Drugs
James C. Robinson, PhD, MPH; Scott Howell, MD, MBA; Steven D. Pearson, MD, MSc
JAMA. 2018;319(21):2169-2170. doi:10.1001/jama.2018.5367
This Viewpoint discusses the challenges of high prices for payers and high access barriers for patients for specialty drugs and how these can be addressed by value-based pricing and value-based patient access.